Lu PJ, Hung MC, Srivastav A, et al. Surveillance of vaccination coverage among adult populations – United States, 2018. MMWR Surveill Summ. 2021;70(3):1-26.
Johnson DR, Nichol KL, Lipczynksi K. Barriers to adult immunization. Am J Med. 2008;127(7 suppl 2):S28-S35.
Benoit SL, Mauldin RF. The “anti-vax” movement: a quantitative report on vaccine beliefs and knowledge across social media. BMC Public Health. 2021;21(1):2106.
Centers for Disease Control and Prevention. Adult immunization schedule. Recommendations for ages 19 years or older, United States, 2022. February 17, 2022. Accessed May 7, 2022. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html#table-age
Schlake T, Thess A, Fotin-Mleczek M, et al. Developing mRNA-vaccine technologies. RNA Biol. 2012;9(11):1319-1330.
Pardi N, Hogan MJ, Porter FW, et al. mRNA vaccines – a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261-279.
Centers for Disease Control and Prevention. When to consider getting J&J/Janssen COVID-19 vaccine. August 24, 2022. Accessed August 31, 2022. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-COVID-19-vaccines.html#janssen-when-to-consider
Tenforde MW, Self WH, Gaglani M, et al. Effectiveness of mRNA vaccination in preventing covid-19–associated invasive mechanical ventilation and death — United States, March 2021–January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(12):459-465.
Steele MK, Couture A, Reed C, et al. Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021. JAMA Netw Open. 2022;5(7):e2220385.
Embi PJ, Levy ME, Naleway AL, et al. Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults – nine states, January–September 2021. MMWR Morb Mortal Wkly Rep. 2021;70(44):1553-1559.
Centers for Disease Control and Prevention. Stay up to date with COVID-19 vaccines including boosters. September 8, 2022. Accessed September 28, 2022. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html?s_cid=11709:covid%20vaccine%20booster:sem.ga:p:RG:GM:gen:PTN.Grants:FY22
Centers for Disease Control and Prevention. Seasonal flu vaccines. August 25, 2022. Accessed August 31, 2022. https://www.cdc.gov/flu/prevent/flushot.htm
Centers for Disease Control and Prevention. How influenza (flu) vaccines are made. August 21, 2021. Accessed August 31, 2022. https://www.cdc.gov/flu/prevent/how-fluvaccine-made.htm
Grohskopf LA, Alyanak E, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 influenza season. MMWR Recomm Rep. 2021;70(5):1-28.
Centers for Disease Control and Prevention. Flu vaccine and people with egg allergies. December 10, 2021. Accessed May 7, 2022. https://www.cdc.gov/flu/prevent/egg-allergies.htm
Demicheli V, Jefferson T, Ferroni E, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2018;2(2):CD001269.
Demicheli V, Jefferson T, Di Pietrantonj C, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2018;2(2):CD004876.
Nelson NP, Weng MK, Hofmeister MG, et al. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020 [published correction appears in MMWR Morb Mortal Wkly Rep. 2021; 70(8): 294]. MMWR Recomm Rep. 2020;69(5):1-38.
Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med. 2007;357(17):1685-1694.
Schillie S, Harris A, Link-Gelles R, et al. Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant. MMWR Morb Mortal Wkly Rep. 2018;67(15):455-458.
Weng MK, Doshani M, Khan MA, et al. Universal hepatitis B vaccination in adults aged 19–59 years: updated recommendations of the Advisory Committee on Immunization Practices – United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(13):477-483.
Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices – United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(4):109-117.
Centers for Disease Control and Prevention. Pneumococcal vaccine recommendations. January 24, 2022. Accessed May 7, 2022. https://www.cdc.gov/vaccines/vpd/pneumo/hcp/recommendations.html
Shah AA. Simplifying pneumococcal immunizations for adults. Am Fam Physician. 2022;105(6):580-581.
Cardemil CV, Dahl RM, James L, et al. Effectiveness of a third dose of MMR vaccine for mumps outbreak control. N Engl J Med. 2017;377(10):947-956.
Vygen-Bonnet S, Hellenbrand W, Garbe E, et al. Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review. BMC Infect Dis. 2020;20:136.
Arbyn M, Xu L, Simoens C, et al. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018;5(5):CD009069.
Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med. 2011;364(5):401-411.
Meites E, Szilagyi PG, Chesson HW, et al. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698-702.
Dooling KL, Guo A, Patel M, et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67(3):103-108.
- Centers for Disease Control and Prevention. Clinical considerations for use of recombinant zoster vaccine (RZV, Shingrix) in immunocompromised adults aged ≥ 19 years. January 20, 2022. Accessed August 31, 2022. https://www.cdc.gov/shingles/vaccination/immunocompromised-adults.html
Centers for Disease Control and Prevention. 2022 outbreak cases and data. September 14, 2022. Accessed September 28, 2022. https://www.cdc.gov/poxvirus/monkeypox/response/2022/index.html
Centers for Disease Control and Prevention. Monkeypox vaccination basics. September 28, 2022. Accessed September 28, 2022. https://www.cdc.gov/poxvirus/monkeypox/vaccines/vaccine-basics.html
Centers for Disease Control and Prevention. JYNNEOS vaccine. August 30, 2022. Accessed September 28, 2022. https://www.cdc.gov/poxvirus/monkeypox/vaccines/jynneos.html
Vaughn JA, Miller RA. Update on immunizations in adults. Am Fam Physician. 2011;84(9):1015-1020.